Average Co-Inventor Count = 4.97
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (15 from 2,405 patents)
2. Other (2 from 832,843 patents)
3. Intervet Inc. (1 from 245 patents)
4. Intervet International B.v. (104 patents)
18 patents:
1. 12319671 - 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
2. 12030872 - N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
3. 11174248 - Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
4. 11161854 - Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
5. 10875847 - Aminopyrazoles as selective janus kinase inhibitors
6. 10766883 - Aminopyrazoles as janus kinase inhibitors
7. 10689369 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof
8. 10442819 - Tricyclic compounds as inhibitors of mutant IDH enzymes
9. 10376729 - Exercise device for paddle sports
10. 10344000 - Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
11. 10287272 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof
12. 10221142 - Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
13. 10072025 - Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors
14. 10059705 - Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors
15. 9957264 - Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors